• Leading experts at the STRIPE Annual Meeting addressed the need for unified guidelines across FDA, EMA, CPIC, and NCCN for DPYD genotype-guided chemotherapy dosing in cancer treatments.
• The innovative MetaCensus platform was introduced as a collaborative tool for evidence sharing and consensus building in pharmacogenetic testing, promoting transparent evaluation processes.
• Pharmacists are playing a crucial role in advancing pharmacogenomics through clinical consultations and research, while emphasizing the importance of multi-disciplinary collaboration in precision medicine implementation.